Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
This is a summary aggregated from CNBC. Read the complete article on the original site:
Read full article at CNBC
